MBOT
Microbot Medical Inc
1.30$
-2.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -34.6% | -84.1% | +227.2% | -44.7% | +509.6% | -29.2% | -36.2% | -43.1% | -12.7% | -27.6% | +1,252.1% | |
| – | -42.6% | -78.2% | +229.7% | -46.7% | +516.3% | -29.7% | -37.1% | -44.5% | -10.1% | -26.5% | +1,271.7% | |
| – | -51.5% | -77.6% | +298.2% | -51.4% | +449.3% | -31.7% | -31.3% | -81.3% | -2.0% | +26.2% | +25.6% | |
| – | -51.5% | -77.6% | +298.2% | -51.4% | +497.4% | -21.2% | -37.1% | -46.6% | -22.9% | -14.3% | +1,336.8% | |
| – | -87.2% | -71.9% | +133.3% | +85.7% | +55.4% | +236.6% | -48.8% | -40.8% | +1,343.7% | -79.8% | -19.7% | |
| – | – | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | +9,671.2% | -99.0% | +69.8% | +187.8% | -12.0% | +350.0% | -13.5% | -18.6% | – | – | – | |
| – | +65.8% | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | -87.2% | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | -18.8% | -92.2% | -36.8% | +350.8% | +17.4% | -64.7% | +21.1% | -5.8% | +70.2% | -34.6% | +59.5% | |
| – | -14.5% | -92.0% | -32.6% | +801.5% | +1.4% | -72.1% | +47.5% | +4.3% | +83.0% | -35.0% | +39.1% | |
| – | -69.8% | -94.6% | – | – | – | +30.8% | +48.7% | +1.8% | -32.5% | -63.4% | +322.9% | |
| – | +40.3% | -57.8% | -61.2% | +707.7% | -54.9% | -3.2% | +1.5% | -58.4% | +207.8% | -53.8% | +209.7% | |
| – | -13.7% | -99.1% | -100.0% | – | – | – | – | – | – | – | – | |
| – | -105.7% | – | +487.5% | -86.7% | +2,271.4% | -22.9% | -40.8% | -49.3% | -38.2% | -21.6% | +2,097.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +92.6% | +1,201.1% | +835.8% | +0.0% | -52.1% | +66.8% | -0.1% | +2.1% | +40.5% | +53.4% | +192.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.